What is the half-life of bisoprolol (beta-blocker) in a typical adult patient with normal renal and liver function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Half-Life of Bisoprolol

The plasma elimination half-life of bisoprolol in adults with normal renal and hepatic function is 9-12 hours, allowing for once-daily dosing. 1

Pharmacokinetic Profile in Normal Function

  • The FDA-approved drug label specifies a plasma elimination half-life of 9-12 hours in patients with normal organ function 1
  • This half-life is slightly longer in elderly patients, partly due to age-related decline in renal function 1
  • Steady-state plasma concentrations are achieved within 5 days of once-daily dosing 1
  • The accumulation factor with once-daily dosing ranges from 1.1 to 1.3, which is minimal and expected from first-order kinetics 1

Comparative Context with Other Beta-Blockers

  • Bisoprolol's half-life is longer than metoprolol (3-5 hours) but shorter than atenolol (6-9 hours in normal renal function) 2
  • During hemodialysis, bisoprolol's half-life is 7.8 hours, demonstrating moderate dialyzability compared to atenolol (4.6 hours HD half-life) or propranolol (3.42 hours HD half-life) 2

Clinical Implications of Balanced Clearance

  • Bisoprolol exhibits balanced clearance with approximately 50% renal elimination (unchanged drug in urine) and 50% hepatic metabolism to inactive metabolites 1, 3
  • This balanced elimination pathway means that even with complete failure of one clearance organ (kidney or liver), the half-life would only double, preventing excessive drug accumulation 4, 3
  • In patients with severe renal impairment (creatinine clearance <40 mL/min), the half-life increases approximately threefold 1
  • In end-stage renal disease (CLCR <5 mL/min), the elimination half-life extends to 24.2 hours 5
  • In patients with liver cirrhosis, the half-life ranges from 8.3 to 21.7 hours (mean 13.5 hours), which is more variable than in renal disease 1, 5

Dosing Considerations Based on Half-Life

  • The 10-12 hour half-life supports once-daily administration in patients with normal organ function 6, 7
  • Peak plasma concentrations occur 2-4 hours after oral dosing 1
  • In severe renal or hepatic failure, maximum dose should not exceed 10 mg once daily to prevent accumulation beyond a factor of 2 4, 5
  • No dose adjustment is necessary for patients with mild to moderate renal or hepatic dysfunction 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.